Treg Modulation With CD28 and IL-6 Receptor Antagonists

NCT04066114 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Living-Donor Kidney Transplant
Kidney Transplant Recipients

Interventions

BIOLOGICAL: lulizumab pegol
BIOLOGICAL: antithymocyte globulin (rabbit)
DRUG: methylprednisolone
BIOLOGICAL: tocilizumab
DRUG: Prednisone
DRUG: everolimus
BIOLOGICAL: belatacept
DRUG: mycophenolate mofetil
DRUG: mycophenolic acid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]